Multimodality Imaging to Predict Response to Systemic Treatment in Patients with Advanced Colorectal Cancer

Monitoring hypoxia and vasculature during bevacizumab treatment in a murine colorectal cancer model

(2014) L. Heijmen et al.   Contrast Media & Molecular Imaging

Comparison of liver SUV using unenhanced CT versus contrast-enhanced CT for attenuation correction in 18F-FDG PET/CT

(2014) Edwin E.G.W. ter Voert et al.   NUCLEAR MEDICINE COMMUNICATIONS

Value of DCE-MRI and FDG-PET/CT in the prediction of response to preoperative chemotherapy with bevacizumab for colorectal liver metastases

(2012) S De Bruyne et al.   BRITISH JOURNAL OF CANCER

Tumour response prediction by diffusion-weighted MR imaging: Ready for clinical use?

(2012) Linda Heijmen et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Pathologic response to bevacizumab-containing chemotherapy in patients with colorectal liver metastases and its correlation with survival

(2012) T. Gruenberger et al.   SURGICAL ONCOLOGY-OXFORD

Serial FDG–PET/CT for early outcome prediction in patients with metastatic colorectal cancer undergoing chemotherapy

(2011) A. Hendlisz et al.   ANNALS OF ONCOLOGY

Relationship between Apparent Diffusion Coefficients at 3.0-T MR Imaging and Gleason Grade in Peripheral Zone Prostate Cancer

(2011) Thomas Hambrock et al.   RADIOLOGY

Diffusion-Weighted MRI of Peripheral Zone Prostate Cancer: Comparison of Tumor Apparent Diffusion Coefficient With Gleason Score and Percentage of Tumor on Core Biopsy

(2010) Courtney A. Woodfield et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

Monoclonal antibodies in the treatment of metastatic colorectal cancer: A review

(2010) Jolien Tol et al.   CLINICAL THERAPEUTICS

FDG PET/CT and diffusion-weighted imaging for breast cancer: prognostic value of maximum standardized uptake values and apparent diffusion coefficient values of the primary lesion

(2010) Masatoyo Nakajo et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Repeatability of Metabolically Active Volume Measurements with 18F-FDG and 18F-FLT PET in Non-Small Cell Lung Cancer

(2010) V. Frings et al.   JOURNAL OF NUCLEAR MEDICINE

Blood oxygen level-dependent MRI for the monitoring of neoadjuvant chemotherapy in breast carcinoma: initial experience

(2010) Bing Fan et al.   MAGNETIC RESONANCE IMAGING

Theoretical models of the diffusion weighted MR signal

(2010) Dmitriy A. Yablonskiy et al.   NMR IN BIOMEDICINE

Primary Human Breast Adenocarcinoma: Imaging and Histologic Correlates of Intrinsic Susceptibility-weighted MR Imaging before and during Chemotherapy

(2010) Sonia P. Li et al.   RADIOLOGY

Beyond RECIST: Molecular and functional imaging techniques for evaluation of response to targeted therapy

(2009) I.M.E. Desar et al.   CANCER TREATMENT REVIEWS

FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0

(2009) Ronald Boellaard et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Monitoring and Predicting Response to Therapy with 18F-FDG PET in Colorectal Cancer: A Systematic Review

(2009) L.-F. de Geus-Oei et al.   JOURNAL OF NUCLEAR MEDICINE

From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors

(2009) R. L. Wahl et al.   JOURNAL OF NUCLEAR MEDICINE

Principles, Techniques, and Applications of T2*-based MR Imaging and Its Special Applications

(2009) Govind B. Chavhan et al.   RADIOGRAPHICS

Apparent Diffusion Coefficient: Potential Imaging Biomarker for Prediction and Early Detection of Response to Chemotherapy in Hepatic Metastases

(2008) Yong Cui et al.   RADIOLOGY